Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intensity Modulated PrOton Therapy in Pediatric BRain Tumors (IMPORT): A Phase 3 Randomized Controlled Trial

NCT07338526 is registered in ClinicalTrials.gov with Tata Memorial Centre as lead sponsor.

NCT NCT07338526
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07338526 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intensity Modulated PrOton Therapy in Pediatric BRain Tumors (IMPORT): A Phase 3 Randomized Controlled Trial
Lead sponsor
Tata Memorial Centre
Phase
Not applicable
Overall status
Recruiting
Start date
August 7, 2025
Completion date
July 7, 2035
Enrollment
94 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brain tumor, pediatric